Lina Johansson

Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.

Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ.

Ironshore Therapeutics, Inc. operates as a pharmaceutical company. The firm offers HLD-200, HLD-900, the morning routine and the delexis products. It develops commercialization of a proprietary drug delivery system. The company was founded by David Gordon MacLeod Lickrish in 2008 and is headquartered in Toronto, Canada.

AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.

Swedish Space Corp. develops, tests and operates space business concepts and projects. Its services include rockets and balloons, satellite management services, space propulsion, aerospace test, safety information, esrange space center, and engineering services. The company was founded in 1972 and is headquartered in Solna, Sweden.

GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden.

Svecia Engineering AB is a world-leading manufacturer of screen printing presses and ancillary equipment used extensively in the graphics, manufacturing and glass industries. Since its start-up in 1948, they have continuously introduced new ideas and products that have made screen printing a modern and reliable manufacturing technology. Today, more than 50 years later, their skills and dedication remain unchanged. Screen printing is still highly visual. Everyone can see how well you handle the mix of colors, materials and formats that characterizes the industry today. And everyone knows that the success of your business depends on the quality of your result. Committed to supplying innovative production solutions tailored to your total needs, their aim to increase your competitive edge and make you a first-choice supplier of screen printing services.

Southern California Biomedical Council, also known as SoCalBio, is an organization that aims to promote the growth and development of the life sciences industry. The non-profit company is based in Los Angeles, CA. The company provides leadership, advocacy, and support to their members, and foster collaboration within the industry. The CEO of the company is Ahmed Enany.

Part of Liberty Global Plc, Virgin Enterprises Ltd. is a British company that provides business support services. The company is based in London, UK. The company was founded in 1972 by Peter Langkilde. The CEO is Lisa Victoria Thomas.

Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL.

Part of Takeda Pharmaceutical Co., Ltd., Takeda Austria GmbH engages in research and development of pharmaceutical products. The company is based in Linz, Austria. Kirsten Detrick has been the CEO of the Austrian company since 2016.

Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA.

VMCEE BV engages in the provision of mobile virtual network operating services. It offers its digital products through inline and traditional retail channels. The company was founded by Jay Metcalfe and Peter Langkilde and is headquartered in Amsterdam, the Netherlands.

Colpman Consulting Ltd. provides financial advisory services. The private company is based in Hampshire, UK.

Takeda Osteuropa Holding GmbH is an investment holding Austrian company. The private company is based in Linz, Austria. Kirsten Detrick has been the CEO of the company since 2016.

Mind The Byte SL develops software for drug discovery.

The Medical Products Agency is a government agency based in Uppsala, Sweden. The agency is responsible for promoting public and animal health in Sweden with regards to pharmaceuticals, medical technology, and cosmetics. The agency is also known as the Swedish Medicines Agency and is tasked with ensuring the safety and efficacy of these products.

Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation.